98%
921
2 minutes
20
Chicken egg yolk antibodies against Vipera lebetina venom were evaluated for their antivenom potential. White leghorn hens were immunized with detoxified V. lebetina venom (γ-irradiated venom). The detoxified venom (200 μg) was mixed with an equal volume of complete Freund's adjuvant and was injected intramuscularly into the hens. The antibodies showed high activity (1.6 LD50/mL) in egg yolks after 12 d of venom injection. The eggs were collected after 12 days, and the egg yolks were removed and washed with purified water to remove any contamination with egg whites. The purification was performed using a method described by Maya Devi et al., followed by gel filtration (Sephadex G-50). The purity and molecular weight of antivenom antibodies (IgY) were determined using electrophoresis, and the molecular weight was found to be approximately 185 kDa. The potency of IgY was 6 LD50/mL (mice), i.e., 1 mL of IgY could neutralize 43.8 μg of standard V. lebetina venom). Our results showed that chicken egg yolk antibodies were effective in neutralizing the lethality and several pharmacological effects of V. lebetina venom and could be used for developing effective antivenom.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685695 | PMC |
http://dx.doi.org/10.4161/21645515.2014.985492 | DOI Listing |
Toxins (Basel)
August 2025
Adaptive Biotoxicology Lab, School of the Environment, University of Queensland, St. Lucia, QLD 4072, Australia.
Venoms of the Palearctic vipers in the genus cause severe procoagulant clinical effects, yet the precise molecular targets remain incompletely defined. To fill this toxicological knowledge gap, we tested five venoms-, , (Turkmenistan and Uzbekistan localities), and -using plasma clotting assays, Factors VII, X, XI, and XII and prothrombin zymogen activation assays, and SDS-PAGE to visualise Factor V (FV) cleavage. All venoms induced extremely rapid clot formation (10.
View Article and Find Full Text PDFNPJ Biodivers
June 2025
Animal Venomics Lab, Fraunhofer Institute for Molecular Biology and Applied Ecology (IME), Ohlebergsweg 12, 35392, Giessen, Germany.
Blunt-nosed vipers (genus Macrovipera) are among the venomous snakes of highest medical relevance in the Palearctic region. Extensive research has been conducted on their venoms, covering toxin composition, biochemistry, function, pathology and biodiscovery. However, these studies are widely dispersed across the scientific literature, almost exclusively focus on biochemistry and drug discovery aspects, and largely neglect the zoological and systematic context of these snakes.
View Article and Find Full Text PDFArch Iran Med
April 2025
Clinical Research Development Unit, Department of Neurology, Bu Ali Hospital, Qazvin University of Medical Sciences, Qazvin, Iran.
Acute cerebral thrombotic stroke following a viper snakebite is a rare occurrence. There have been a few documented cases of cerebral infarctions resulting from envenomation by various viper species. However, none of these reports have specifically detailed instances of stroke induced by envenomation or vessel occlusion without concurrent cerebral infarction.
View Article and Find Full Text PDFToxicon
June 2025
Microbiology and Reference Laboratory and Biological Products Department, Republic of Turkish Ministry of Health General Directorate of Public Health, 06430, Ankara, Turkiye. Electronic address:
Objective: The aim was to investigate the paraspecific efficiacy of the National HSGM-polyvalent snake antivenom, which is used in the treatment of snakebite poisoning cases in Turkey, on Vipera ammodytes ammodytes and Vipera berus berus snakes that live widely in Europe and Montivipera raddei venoms that live in Turkey and Armenia.
Method: The paraspecific efficiacy of the antivenom on these three venoms were determined using the test method for neutralization of the lethal effect of the venom in mice specified in the European pharmacopoeia.
Conclusion: It was observed that HSGM-PVSAV produced using Vipera ammodytes montandoni, Macrovipera lebetina obtusa and Montivipera xanthina venoms showed an effect above the European pharmacopoeia limits against all three snake venoms.
Toxins (Basel)
December 2024
Adaptive Biotoxicology Lab, School of the Environment, University of Queensland, St Lucia, QLD 4072, Australia.
This study examined the pathophysiological effects of venoms from neonate and adult specimens of the viperid snake , focusing on their ability to activate various blood clotting factors in human plasma. All venoms exhibited strong procoagulant properties. In concentration-response tests, the clotting potency of the neonate venoms fell within the range of their parents' maximum clotting velocities and areas under the curve.
View Article and Find Full Text PDF